3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Heart Diseases
3
Vascular Diseases
2
Small Cell Lung Carcinoma
2
Cardiovascular Diseases
2
Cardiotoxicity
2
Triple Negative Breast Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Cancer Resectable
1
Ovarian Carcinosarcoma
1
Neoplasms, Second Primary
1
Myelodysplastic Syndromes
1
Metabolic Diseases
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Immune-related Adverse Event
1
Hematologic Neoplasms
1
Heart Failure
1
Esophageal Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Colorectal Neoplasms
1
Colorectal Cancer Metastatic
1
Carcinoma, Hepatocellular
1
Cancer Therapy-related Cardiovascular Toxicity
1
Breast Neoplasms
1
Advanced Ovarian Cancer
1
Interventions
fludarabine
2
Busulfan
2
thymoglobulin
1
fludarabine phosphate
1
bicalutamide
1
Testosterone
1
Saline Solution
1
Powders
1
Nutrition Assessment
1
Metformin
1
Mesna
1
Melphalan
1
Influenza Vaccines
1
Honey
1
Heparin
1
Gonadotropin-Releasing Hormone
1
Gastric Bypass
1
Exercise
1
Eating
1
Cyclophosphamide
1
Clofarabine
1
Caloric Restriction
1
Antineoplastic Agents
1
Antilymphocyte Serum
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Metabolic Diseases
×
Antineoplastic Agents
×
Clear all
NCT03882580
2023-04-24
NEOCARDIO
Groupe Hospitalier Pitie-Salpetriere
Unknown
5,000 enrolled